PERSIST study (PERgoveriS In Stratified Treatment) for ART

• Research type

  Research Study

• Full title

  A phase IIIB, multicentre, multinational, randomized, open-label trial to compare the efficacy and safety of ovarian stimulation with GONAL-f® day 1 to day 5 followed by Pergoveris® starting day 6 to Pergoveris® starting day 1 in women between 36 and 40 years of age undergoing assisted reproductive technique (ART)

• IRAS ID

  77598

• Contact name

  Nitish Narvekar

• Contact email

  Nitish.Narvekar@nhs.net

• Sponsor organisation

  Merck Serono S.A. - Geneva

• Eudract number

  2010-023534-23

• Clinicaltrials.gov Identifier

  NCT01297465

• Research summary

  Research Summary not published at request of researcher - exceeds word count

• REC name

  East Midlands - Derby Research Ethics Committee

• REC reference

  11/EM/0128

• Date of REC Opinion

  1 Aug 2011

• REC opinion

  Further Information Favourable Opinion